Status:
NOT_YET_RECRUITING
A Single Center Prospective Study in an Estimated 570 Patients Who Underwent Genetic Screening at UZ Brussel in the Context of a Primary Cardiac Arrhythmia. Patients Showing a Variant Class 3,4 or 5 in SCN4A or CLCN1 Will Undergo a Clinical and Electrophysiological Review After IC.
Lead Sponsor:
Universitair Ziekenhuis Brussel
Conditions:
Non Dystrophic Myotonia
Arrythmia, Cardiac
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
A prospective interventional single-center study will be conducted. The study includes clinically diagnosed Intramuros PCA-patients who underwent a PCA gene panel of 113 genes (see Appendix 1) in the ...
Detailed Description
A prospective interventional single-center study will be conducted. The study includes clinically diagnosed Intramuros PCA-patients who underwent a PCA gene panel of 113 genes (see Appendix 1) in the ...
Eligibility Criteria
Inclusion
- Patients with PCA who underwent a genetic analysis with a PCA gene panel since 2021 (since the panel involves 112 genes including SCN4A).
- Male and female gender.
Exclusion
- Genetic analysis before 2021
- Patients without cardiac screening in UZ Brussel
Key Trial Info
Start Date :
December 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2027
Estimated Enrollment :
570 Patients enrolled
Trial Details
Trial ID
NCT07183059
Start Date
December 15 2025
End Date
September 30 2027
Last Update
December 1 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.